Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
about
Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medicationsLong-term pathological consequences of prenatal infection: beyond brain disorders.Blood cell count in antipsychotic-naive patients with non-affective psychosis.
P2860
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@ast
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@en
type
label
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@ast
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@en
prefLabel
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@ast
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@en
P2860
P50
P1476
Metabolic effects of olanzapine in patients with newly diagnosed psychosis.
@en
P2093
Brian Miller
Emilio Fernandez-Egea
P2860
P304
P356
10.1097/JCP.0B013E31820FCEA3
P407
P577
2011-04-01T00:00:00Z